RYTM
Rhythm Pharmaceuticals, Inc.Company with tickers: RYTM
CIK
1649904
CUSIP
76243J105
Shares Outstanding
68,532,607
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $32,704,000 | USD | 2025-03-31 | 10-Q | 2026-05-05 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $36,973,000 | USD | 2025-03-31 | 10-Q | 2026-05-05 |
| Operating Income | $-47,004,000 | USD | 2025-03-31 | 10-Q | 2026-05-05 |
| Net Income | $-49,498,000 | USD | 2025-03-31 | 10-Q | 2026-05-05 |
| EPS (Basic) | $-0.81 | USD/shares | 2025-03-31 | 10-Q | 2026-05-05 |
| EPS (Diluted) | $-0.81 | USD/shares | 2025-03-31 | 10-Q | 2026-05-05 |